Pharmacokinetics of an Oral Once‐a‐Day Controlled‐Release Oxybutynin Formulation Compared with Immediate‐Release Oxybutynin
- 8 March 1999
- journal article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 39 (3) , 289-296
- https://doi.org/10.1177/009127009903900313
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Comparison of Oxybutynin and its Active Metabolite, N-Desethyl-Oxybutynin, in the Human Detrusor and Parotid GlandJournal of Urology, 1997
- Simultaneous First‐Order and Capacity‐Limited Elimination Kinetics After Oral Administration of VerapamilThe Journal of Clinical Pharmacology, 1996
- Nocturnal scintigraphic imaging to investigate the gastrointestinal transit of dosage formsJournal of Controlled Release, 1992
- Measurement of oxybutynin and its N-desethyl metabolite in plasma, and its application to pharmacokinetic studies in young, elderly and frail elderly volunteersXenobiotica, 1992
- Pharmacodynamic Profile of Verapamil in Relation to Absolute BioavailabilityJournal of Cardiovascular Pharmacology, 1991
- Mebolism of drugs and other xenobiotics in the gut lumen and wallPharmacology & Therapeutics, 1990
- The treatment of detrusor instability in postmenopausal women with oxybutynin chloride: a double blind placebo controlled studyBJOG: An International Journal of Obstetrics and Gynaecology, 1990
- Transit of pharmaceutical dosage forms through the small intestine.Gut, 1986
- Time‐Dependent Absorption of Theophylline in ManThe Journal of Clinical Pharmacology, 1984
- Metabolism of oxybutynin: Establishment of desethyloxybutynin and oxybutyninN-oxide formation in rat liver preparations using deuterium substitution and gas chromatographic mass spectrometric analysisJournal of Mass Spectrometry, 1981